Article(id=1325224431932551740, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1325224405504242054, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2026.01.014, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1750608000000, receivedDateStr=2025-06-23, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1793887726051, onlineDateStr=2026-11-05, pubDate=1767974400000, pubDateStr=2026-01-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793887726051, onlineIssueDateStr=2026-11-05, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793887726051, creator=13701087609, updateTime=1793887726051, updator=13701087609, issue=Issue{id=1325224405504242054, tenantId=1146029695717560320, journalId=1319690329412173987, year='2026', volume='47', issue='1', pageStart='1', pageEnd='103', issueExtLink='null', onlineDate='null', pubDate='1767974400000', pubDateStr='2026-01-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1793887719751, creator='13701087609', updateTime=1793934856625, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1325422111933735069, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1325224405504242054, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1325422111933735070, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1325224405504242054, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=93, endPage=98, ext={EN=ArticleExt(id=1325224432150655549, articleId=1325224431932551740, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Research progress of antibody-coupled drug-related interstitial lung disease, columnId=1325221194584162830, journalTitle=World Clinical Drug, columnName=Review, runingTitle=null, highlight=null, articleAbstract=
As a cutting-edge and potential novle class of anti-tumor drug, antibody-drug conjugates(ADC)have shown significant efficacy in a variety of tumor treatments. However, with the widespread use of ADC, the related adverse reactions have attracted more and more attention. Interstitial lung disease(ILD) is a serious and life-threatening adverse reactions, which is usually characterized by progressive dyspnea, cough, chest pain, hypoxemia and low-grade fever. The mechanism of ADC-related ILD is complex, involving multi-dimensional factors, and due to the lack of specific diagnostic criteria of ILD, high vigilance must be maintained in clinical practice, problems should be identified early and timely intervention. This review aims to sort out the pathogenesis, diagnostic evaluation and management strategies of ADC-related ILD, helping clinicians understand and master the characteristics of pulmonary toxicity of ADC, so as to reduce and avoid serious adverse reactions and ensure the effectiveness and safety of ADC therapy in clinical application.
, authors=Zhangxiang JIAN
1, Weiping ZHANG
2, *, authorsList=Zhangxiang JIAN, Weiping ZHANG, authorCompany=null, correspAuthors=Weiping ZHANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1325224432414896702, articleId=1325224431932551740, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=抗体偶联药物相关间质性肺病的研究进展, columnId=1325221194743546384, journalTitle=世界临床药物, columnName=综述评论, runingTitle=null, highlight=null, articleAbstract=
抗体偶联药物(antibody-drug conjugates,ADC)作为一种前沿且极具潜力的新型抗肿瘤药物,已在多种肿瘤治疗中展现出显著疗效。然而,随着ADC的广泛应用,其相关不良反应备受关注。其中间质性肺病(interstitial lung disease,ILD)是一种严重程度高、可能危及生命的不良反应,通常表现为逐渐加重的呼吸困难、咳嗽、胸痛、低氧血症和低热。ADC相关ILD的发生机制复杂,涉及多维度因素,且由于ILD缺乏特异性诊断标准,在临床实践中必须高度警惕,应早期识别问题并采取干预措施。本文旨在对ADC相关ILD的发病机制、诊断评估及管理策略等方面进行梳理,帮助临床医生了解和掌握ADC的肺毒性特征,从而减少和避免严重不良反应发生,确保其临床应用的有效性和安全性。
, authors=简张翔
1, 张卫平
2, *, authorsList=简张翔, 张卫平, authorCompany=null, correspAuthors=张卫平, authorNote=
, correspAuthorsNote=
张卫平,主任医师,研究方向:肿瘤的综合治疗。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=v8HxWoiGbAprILCWccWquw==, magXml=Rppao9QIy4R7O60JLH7v0w==, pdfUrl=null, pdf=VVJRRVflLXv4ILjdkB/AJQ==, pdfFileSize=1410138, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=RJJw5xGty9ObfkXkP8ZMGw==, mapNumber=null, fund=null)}, authors=[Author(id=1325224432809161286, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325224432888853064, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, authorId=1325224432809161286, language=EN, stringName=Zhangxiang JIAN, firstName=Zhangxiang, middleName=null, lastName=JIAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, address=
1.The Third School of Clinical Medicine, Zhejiang Chinese Medical University, Hanghzou 310053, Zhejiang Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325224436407874121, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, authorId=1325224432809161286, language=CN, stringName=简张翔, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, address=
1.浙江中医药大学第三临床医学院,浙江 杭州 310053, bio={"content":"
简张翔,硕士研究生,研究方向:肿瘤的综合治疗。
"}, bioImg=null, bioContent=
简张翔,硕士研究生,研究方向:肿瘤的综合治疗。
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325224432633000511, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, xref=1., ext=[AuthorCompanyExt(id=1325224432637194816, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, companyId=1325224432633000511, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.The Third School of Clinical Medicine, Zhejiang Chinese Medical University, Hanghzou 310053, Zhejiang Province, China), AuthorCompanyExt(id=1325224432645583425, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, companyId=1325224432633000511, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.浙江中医药大学第三临床医学院,浙江 杭州 310053)])]), Author(id=1325224436516926027, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325224436638560845, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, authorId=1325224436516926027, language=EN, stringName=Weiping ZHANG, firstName=Weiping, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
2, *, address=
2.Department of Oncology, The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hanghzou 310005, Zhejiang Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325224436751807054, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, authorId=1325224436516926027, language=CN, stringName=张卫平, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
2, *, address=
2.浙江中医药大学附属第三医院肿瘤科,浙江 杭州 310005, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325224432733663810, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, xref=2., ext=[AuthorCompanyExt(id=1325224432742052419, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, companyId=1325224432733663810, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.Department of Oncology, The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hanghzou 310005, Zhejiang Province, China), AuthorCompanyExt(id=1325224432746246724, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, companyId=1325224432733663810, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.浙江中医药大学附属第三医院肿瘤科,浙江 杭州 310005)])])], keywords=[Keyword(id=1325224436898607695, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, language=EN, orderNo=1, keyword=antibody-coupled drugs), Keyword(id=1325224436974105168, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, language=EN, orderNo=2, keyword=interstitial lung disease), Keyword(id=1325224437041214033, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, language=EN, orderNo=3, keyword=adverse drug events and management), Keyword(id=1325224437108322898, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, language=EN, orderNo=4, keyword=pathogenesis), Keyword(id=1325224437171237459, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, language=CN, orderNo=1, keyword=抗体偶联药物), Keyword(id=1325224437246734932, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, language=CN, orderNo=2, keyword=间质性肺病), Keyword(id=1325224437334815317, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, language=CN, orderNo=3, keyword=药品不良事件与管理), Keyword(id=1325224437410312790, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, language=CN, orderNo=4, keyword=发病机制)], refs=[Reference(id=1325224439272583768, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=BIRRER MJ, MOORE KN, BETELLA I,
et al. Antibody-drug conjugate-based therapeutics: state of the science[J]. J Natl Cancer Inst, 2019, 111(6): 538-549., articleTitle=null, refAbstract=null), Reference(id=1325224439339692633, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=赵丽丽, 朱玉强, 李朋, 等. 抗体偶联药物的研究进展[J].中国医药工业杂志, 2025, 56(10): 1243-1251., articleTitle=null, refAbstract=null), Reference(id=1325224439394218586, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=NATSUME A, NIWA R, SATOH M. Improving effector functions of antibodies for cancer treatment: enhancing ADCC and CDC[J]. Drug Des Devel Ther, 2009, 3: 7-16., articleTitle=null, refAbstract=null), Reference(id=1325224439503270491, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=DUMONTET C, REICHERT JM, SENTER PD,
et al.Antibody-drug conjugates come of age in oncology[J]. Nat Rev Drug Discov, 2023, 22(8): 641-661., articleTitle=null, refAbstract=null), Reference(id=1325224439582962268, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=FU Z, LI S, HAN S,
et al. Antibody drug conjugate: the"biological missile" for targeted cancer therapy[J]. Signal Transduct Target Ther, 2022, 7(1): 93., articleTitle=null, refAbstract=null), Reference(id=1325224439671042653, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=SWAIN SM, NISHINO M, LANCASTER LH,
et al.Multidisciplinary clinical guidance on trastuzumab deruxtecan(T-DXd)-related interstitial lung disease/pneumonitis-focus on proactive monitoring, diagnosis, and management[J].Cancer Treat Rev, 2022, 106: 102378., articleTitle=null, refAbstract=null), Reference(id=1325224439759123038, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=POWELL CA, MODI S, IWATA H,
et al. Pooled analysis of drug-related interstitial lung disease and/or pneumonitis in nine trastuzumab deruxtecan monotherapy studies[J]. ESMO Open, 2022, 7(4): 100554., articleTitle=null, refAbstract=null), Reference(id=1325224439931089503, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=MA Z, ZHANG Y, ZHU M,
et al. Interstitial lung disease associated with anti-HER2 anti-body drug conjugates:Results from clinical trials and the WHO's pharmacovigilance database[J]. Expert Rev Clin Pharmacol, 2022, 15(11):1351-1361., articleTitle=null, refAbstract=null), Reference(id=1325224440014975584, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=ABUHELWA Z, ALLOGHBI A, ALQAHTANI A,
et al.Trastuzumab deruxtecan-induced interstitial lung disease/pneumonitis in ERBB2-positive advanced solid malignancies:a systematic review[J]. Drugs, 2022, 82(9): 979-987., articleTitle=null, refAbstract=null), Reference(id=1325224440178553441, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=MA P, TIAN H, SHI Q,
et al. High risks adverse events associated with trastuzumab emtansine and trastuzumab deruxtecan for the treatment of HER2-positive/mutated malignancies: a pharmacovigilance study based on the FAERS database[J]. Expert Opin Drug Saf, 2023, 22(8):685-696., articleTitle=null, refAbstract=null), Reference(id=1325224443701768802, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=KUMAGAI K, AIDA T, TSUCHIYA Y,
et al. Interstitial pneumonitis related to trastuzumab deruxtecan, a human epidermal growth factor receptor 2‐targeting Ab-drug conjugate, in monkeys[J]. Cancer Sci, 2020, 111(12): 4636-4645., articleTitle=null, refAbstract=null), Reference(id=1325224443794043491, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=GIUGLIANO F, CORTI C, TARANTINO P,
et al. Bystander effect of antibody-drug conjugates: fact or fiction?[J]. Curr Oncol Rep, 2022, 24(7): 809-817., articleTitle=null, refAbstract=null), Reference(id=1325224443903095396, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=HINRICHS MJM, DIXIT R. Antibody drug conjugates:nonclinical safety considerations[J]. AAPS J, 2015, 17(5):1055-1064., articleTitle=null, refAbstract=null), Reference(id=1325224443995370085, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=CHAI M, LI L, WU H,
et al. Lung toxicity induced by anti-HER2 antibody-drug conjugates for breast cancer[J]. Crit Rev Oncol Hematol, 2024, 195: 104274., articleTitle=null, refAbstract=null), Reference(id=1325224444062478950, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=BELLUOMINI L, AVANCINI A, SPOSITO M,
et al.Antibody-drug conjugates(ADCs) targeting TROP-2 in lung cancer[J]. Expert Opin Biol Ther, 2023, 23(11): 1077-1087., articleTitle=null, refAbstract=null), Reference(id=1325224444154753639, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=POWELL CA, CAMIDGE DR, MODI S,
et al. Risk factors for interstitial lung disease in patients treated with trastuzumab deruxtecan from two interventional studies[J].Ann Oncol, 2020, 31: S357-S358., articleTitle=null, refAbstract=null), Reference(id=1325224444242834024, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=YIN O, IWATA H, LIN CC,
et al. Exposure‐response relationships in patients with HER2‐positive metastatic breast cancer and other solid tumors treated with trastuzumab deruxtecan[J]. Clin Pharmacol Ther, 2021, 110(4): 986-996., articleTitle=null, refAbstract=null), Reference(id=1325224444309942889, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=JOHKOH T, LEE K S, NISHINO M,
et al. Chest CT diagnosis and clinical management of drug-related pneumonitis in patients receiving molecular targeting agents and immune checkpoint inhibitors: a position paper from the fleischner society[J]. Chest, 2021, 159(3): 1107-1125., articleTitle=null, refAbstract=null), Reference(id=1325224444385440362, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=BABA T, KUSUMOTO M, KATO T,
et al. Clinical and imaging features of interstitial lung disease in cancer patients treated with trastuzumab deruxtecan[J]. Int J Clin Oncol,2023, 28(12): 1585-1596., articleTitle=null, refAbstract=null), Reference(id=1325224444456743531, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=XU C, CHEN Z, XIA Y,
et al. Clinical best practices in interdisciplinary management of human epidermal growth factor receptor 2 antibody‐drug conjugates-induced interstitial lung disease/pneumonitis: an expert consensus in China[J].Cancer, 2024, 130(S17): 3054-3066., articleTitle=null, refAbstract=null), Reference(id=1325224444561601132, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=KUBO K, AZUMA A, KANAZAWA M,
et al. Consensus statement for the diagnosis and treatment of drug-induced lung injuries[J]. Respir Investig, 2013, 51(4): 260-277., articleTitle=null, refAbstract=null), Reference(id=1325224444632904301, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=MULLER NL, WHITE DA, JIANG H,
et al. Diagnosis and management of drug-associated interstitial lung disease[J].Br J Cancer, 2004, 91(Supply 2): S24-S30., articleTitle=null, refAbstract=null), Reference(id=1325224444704207470, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=CONTE P, ASCIERTO PA, PATELLI G,
et al. Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment[J]. ESMO Open, 2022,7(2): 100404., articleTitle=null, refAbstract=null), Reference(id=1325224444779704943, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=HU Y, WANG LS, JIN YP,
et al. Serum krebs von den lungen‐6 level as a diagnostic biomarker for interstitial lung disease in Chinese patients[J]. Clin Respir J, 2017, 11(3):337-345., articleTitle=null, refAbstract=null), Reference(id=1325224444855202416, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=PARK HK, YOON CS, NA YO,
et al. Serum KL-6 levels predict the occurrence and severity of treatment-related interstitial lung disease in lung cancer[J]. Sci Rep, 2023,13(1): 18126., articleTitle=null, refAbstract=null), Reference(id=1325224444926505585, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=CHETTA A, MARANGIO E, OLIVIERI D. Pulmonary function testing in interstitial lung diseases[J]. Respiration,2004, 71(3): 209-213., articleTitle=null, refAbstract=null), Reference(id=1325224445018780274, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=TARANTINO P, TOLANEY SM. Detecting and managing T-DXd-related interstitial lung disease: the five "S" rules[J].JCO Oncol Pract, 2023, 19(8): 526-527., articleTitle=null, refAbstract=null), Reference(id=1325224445102666355, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=张剑, 韩茜, 徐菲, 等. 德曲妥珠单抗所致间质性肺病全程管理策略[J]. 中国癌症杂志, 2024, 34(12): 1067-1079., articleTitle=null, refAbstract=null), Reference(id=1325224445173969524, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=RUGO HS, BIANCHINI G, CORTES J,
et al. Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer[J]. ESMO Open, 2022, 7(4):100553., articleTitle=null, refAbstract=null), Reference(id=1325224445295604341, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=抗肿瘤药物相关间质性肺病诊治专家共识专家委员会. 抗肿瘤药物相关间质性肺病诊治专家共识[J]. 中华肿瘤杂志, 2022, 44(7): 693-702., articleTitle=null, refAbstract=null), Reference(id=1325224445366907510, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=BALAJI A, HSU M, LIN CT,
et al. Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes[J]. J Immunother Cancer, 2021, 9(1): e001731., articleTitle=null, refAbstract=null), Reference(id=1325224445459182199, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=RUGO H S, TOKUNAGA E, IWATA H,
et al. Pooled analysis of trastuzumab deruxtecan retreatment after recovery from grade 1 interstitial lung disease/pneumonitis[J]. Ann Oncol,2025, 36(11): 1389-1399., articleTitle=null, refAbstract=null), Reference(id=1325224445534679672, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=NAM S, LIM SM, CHO BC,
et al. Successful rechallenge of trastuzumab deruxtecan after drug-induced interstitial lung disease in a NSCLC with HER2 mutation: a case report[J].JTO Clin Res Rep, 2024, 5(2): 100628., articleTitle=null, refAbstract=null), Reference(id=1325224445614371449, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=DE WEGER VA, SCHUTTE T, KONINGS IRHM,
et al. Successful trastuzumab-deruxtecan rechallenge after interstitial lung disease: a case report[J]. J Breast Cancer,2023, 26(5): 519-523., articleTitle=null, refAbstract=null), Reference(id=1325224445794726522, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=马骏威, 刘永辉, 任连杰. 抗体偶联药物的小分子部分药学研究考虑[J]. 中国医药工业杂志, 2025, 56(11): 1464-1470., articleTitle=null, refAbstract=null)], funds=[Fund(id=1325224437548724823, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, awardId=GZY-KJS-ZJ-2025-012, language=CN, fundingSource=2025年度国家中医药综合改革示范区科技共建重大项目(GZY-KJS-ZJ-2025-012), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1325224432633000511, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, xref=1., ext=[AuthorCompanyExt(id=1325224432637194816, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, companyId=1325224432633000511, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.The Third School of Clinical Medicine, Zhejiang Chinese Medical University, Hanghzou 310053, Zhejiang Province, China), AuthorCompanyExt(id=1325224432645583425, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, companyId=1325224432633000511, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.浙江中医药大学第三临床医学院,浙江 杭州 310053)]), AuthorCompany(id=1325224432733663810, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, xref=2., ext=[AuthorCompanyExt(id=1325224432742052419, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, companyId=1325224432733663810, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.Department of Oncology, The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hanghzou 310005, Zhejiang Province, China), AuthorCompanyExt(id=1325224432746246724, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224431932551740, companyId=1325224432733663810, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.浙江中医药大学附属第三医院肿瘤科,浙江 杭州 310005)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2026.01.014, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2026.01.014, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2026.01.014, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2026.01.014, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1767974400000, fullTextJson=null, articleText=null, reference=null)